RCOphth press statement -Ranibizumab for DMO Appeal 29/07/2011 The Royal College of Ophthalmologists has carefully reviewed the Final Appraisal Determination (FAD) relating to ‘Ranibizumab for the treatment of diabetic macular oedema’ published by NICE and has decided to make a formal appeal against the decision.
Short Notes from Professional Standards Committee July 2011 29/07/2011 The Short Notes from July's Professional Standards Committee are now available (Member's Login Required)
Patient Safety Update July 2011 29/07/2011 Patient Safety Update – a short and well informed update written by Mr Simon Kelly has been added to the College website.
Clinical Excellence Awards 2012 Information 28/07/2011 Update from ACCEA 29th July, 2011 Dear National Nominating Bodies, Please find below an announcement from the ACCEA Chair and Medical Director. This information will appear on the ACCEA website in the next few days. 2011 Round ACCEA usually aims to notify successful candidates and publish the list...
Paediatric Sub-committee Statement on Children’s Eye Health Campaign 2011 26/07/2011 Notice from the Paediatric Sub-committee regarding the Association of Optometrists (AOP) campaign on sight tests for children.
RCOphth Press Statement - Ranubizumab for DMO 20/07/2011 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) Final Appraisal Determination Ranibizumab for the treatment of diabetic macular oedema (DMO) On 15th July NICE released their final appraisal of the use of ranibizumab (Lucentis) for the treatment of diabetic macular oedema. NICE...
Transfer of Care Guidance from the Royal Pharmaceutical Society 20/07/2011 The Royal Pharmaceutical Society, in collaboration with other royal colleges, patients, health and social care professionals has developed professional guidance that is closely mapped to a range of related national initiatives and guidance.
Ophthalmic Public Health: the invisible public health time bomb 20/07/2011 Sight loss is set to double by 2050, despite half of this being avoidable through early intervention and diagnosis. The College calls for public health outcome measures to include an eye health indicator.
GMC consultation on new child protection guidance 18/07/2011 'Protecting children and young people: the responsibilities of all doctors.' Important consultantation for all doctors not just those primarily involved in treating children.
Update on MHRA Medical Device Alert: Cryomatic probes manufactured by Keeler Ltd 18/07/2011 All probes are affected. The instructions for use contain inadequately validated re-processing methods. As a result there is a risk of cross infection. (MDA/2011/071 and update 18 July 2011 MDA/2011/081).